Evidence map›Paper›PMID 35315358›Full record

ArticleJCI insight2022

CFTR bearing variant p.Phe312del exhibits function inconsistent with phenotype and negligible response to ivacaftor.

Karen S Raraigh, Kathleen C Paul, Jennifer L Goralski, Erin N Worthington, Anna V Faino, Stanley Sciortino, Yiting Wang, Melis A Aksit, Hua Ling, Derek L Osorio and 11 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Establishment of a conditionally reprogrammed primary eccrine sweat gland culture for evaluation of tissue-specific CFTR function.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Article
  6. CFTR Modulators: From Mechanism to Targeted Therapeutics.Handbook of experimental pharmacology · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Karen S RaraighJohns Hopkins University, Baltimore, Maryland, USA.
Kathleen C PaulJohns Hopkins University, Baltimore, Maryland, USA.
Jennifer L GoralskiUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Erin N WorthingtonUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Anna V FainoSeattle Children's Research Institute, Seattle, Washington, USA.
Stanley SciortinoCalifornia Department of Public Health, Genetic Disease Screening Program, Richmond, California, USA.
Yiting WangUniversity of Bristol, Bristol, United Kingdom.
Melis A AksitJohns Hopkins University, Baltimore, Maryland, USA.
Hua LingJohns Hopkins University, Baltimore, Maryland, USA.
Derek L OsorioJohns Hopkins University, Baltimore, Maryland, USA.
Frankline M OnchiriSeattle Children's Research Institute, Seattle, Washington, USA.
Shivani U PatelJohns Hopkins University, Baltimore, Maryland, USA.
Christian A MerloJohns Hopkins University, Baltimore, Maryland, USA.
Kristina MontemayorJohns Hopkins University, Baltimore, Maryland, USA.
Ronald L GibsonUniversity of Washington, Seattle, Washington, USA.
Natalie E WestJohns Hopkins University, Baltimore, Maryland, USA.
Amita ThakerarRosalind Franklin University of Medicine and Science, Center for Genetic Diseases, North Chicago, Illinois, USA.
Robert J BridgesRosalind Franklin University of Medicine and Science, Center for Genetic Diseases, North Chicago, Illinois, USA.
David N SheppardUniversity of Bristol, Bristol, United Kingdom.
Neeraj SharmaJohns Hopkins University, Baltimore, Maryland, USA.
Garry R CuttingJohns Hopkins University, Baltimore, Maryland, USA.
Johns Hopkins University · USRosalind Franklin University of Medicine and Science · USUniversity of Bristol · GBUniversity of North Carolina at Chapel Hill · USCalifornia Department of Public Health · USUniversity of Washington · US

Funding

MOLECULAR GENETICS OF CYSTIC FIBROSISR01DK044003 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Garry R Cutting · 1991 to 2026
$6.7M
NIDDK NIH HHS R01 DK044003
6 · The paper itself

Abstract

The chloride channel dysfunction caused by deleterious cystic fibrosis transmembrane conductance regulator (CFTR) variants generally correlates with severity of cystic fibrosis (CF). However, 3 adults bearing the common severe variant p.Phe508del (legacy: F508del) and a deletion variant in an ivacaftor binding region of CFTR (p.Phe312del; legacy: F312del) manifested only elevated sweat chloride concentration (sw[Cl-]; 87-105 mEq/L). A database review of 25 individuals with F312del and a CF-causing variant revealed elevated sw[Cl-] (75-123 mEq/L) and variable CF features. F312del occurs at a higher-than-expected frequency in the general population, confirming that individuals with F312del and a CF-causing variant do not consistently develop overt CF features. In primary nasal cells, CFTR bearing F312del and F508del generated substantial chloride transport (66.0% ± 4.5% of WT-CFTR) but did not respond to ivacaftor. Single-channel analysis demonstrated that F312del did not affect current flow through CFTR, minimally altered gating, and ablated the ivacaftor response. When expressed stably in CF bronchial epithelial (CFBE41o-) cells, F312del-CFTR demonstrated residual function (50.9% ± 3.3% WT-CFTR) and a subtle decrease in forskolin response compared with WT-CFTR. F312del provides an exception to the established correlation between CFTR chloride transport and CF phenotype and informs our molecular understanding of ivacaftor response.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorAminophenolsChloridesHumansPhenotypeQuinolonesAminophenolsCFTR protein, humanChloridesCystic Fibrosis Transmembrane Conductance RegulatorivacaftorQuinolonesGeneticsGenetic variation

Identifiers

PMID35315358
PMCPMC8986068
OpenAlexW4220750917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.